01Feb
01Feb
Frost & Sullivan Recognizes Wasabi for Its Hot Cloud Storage Solution with 2017 North American Technology Innovation Award
Based on its recent analysis of the Hot Cloud Storage industry, Frost & Sullivan recognizes Wasabi Technologies Inc. (Wasabi) with the 2017 North American Technology Innovation Award. Wasabi is a Boston-based cloud storage startup that offers hot cloud storage solutions as a service. Read more >>
01Feb
Baby boomers increasingly interested in tuition benefits
Laurel Taylor, founder and CEO of student debt relief and refinancing firm FutureFuel.io, says that more U.S. employers are seeing their older workers sign up for this benefit. Read more >>
30Jan
Corbus Pharmaceuticals Announces Agreement with FDA on Phase 2b Cystic Fibrosis Study Design with Pulmonary Exacerbations as Sole Primary Endpoint
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, today announced that it has reached agreement with the U.S. Food and Drug Administration ("FDA") regarding the design of its next study of lenabasum (formerly known as anabasum), a novel, oral, pro-resolving drug, in the treatment of cystic fibrosis ("CF"). Read more >>
29Jan
RetroSense founder Sean Ainsworth named CEO of Seattle biotech
Sean Ainsworth hopes to strike biotech gold, again, joining Seattle-based Immusoft Corp. as CEO and chairman. Read more >>
25Jan
Myomo Completes Repayment of Loan to the Massachusetts Life Sciences Center
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, and the Massachusetts Life Sciences Center (MLSC) today celebrated Myomo’s repayment of a $750,000 accelerator loan provided by the MLSC in 2011. Myomo completed repayment of the loan, which totaled $1,350,618 with interest, on December 13, 2017. Myomo Chairman and CEO Paul R. Gudonis presented a ceremonial check to Travis McCready, President and CEO of MLSC, during a ceremony at Myomo’s headquarters in the Cambridge...
24Jan
‘Bone Glue’ Experiments on the ISS Test Possible Treatment for Osteoporosis
“If we can show that our material stimulates the production of new bone in the space environment, that will have a translational value back on Earth, that it could be used to someday treat patients with osteoporosis,” said Brian Hess, founder and CEO of Launchpad Medical, which created the glue. “But it could also be a material to help treat astronauts from the effects of deep space travel. That’s obviously a secondary reason of why we are studying this in...
24Jan
Beauty as you know it is changing.
Pixability’s new study analyzes the YouTube practices of 215 beauty brands and 182,621 independent YouTube beauty creators who create YouTube videos focused on makeup, skincare, hair, nails, and perfume. Read more >>
23Jan
Video system has ‘transformative potential’ for blind patients
The eSight system (eSight Corp., Toronto, Canada) is a set of electronic glasses, which look similar to the 3D glasses that video gamers use, has a controller so users can magnify an image to great extents. Time magazine named the system one of the 25 best inventions of 2017. Read more >>
22Jan